These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19712557)

  • 1. Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
    Mo D; Saravelos S; Metwally M; Makris M; Li TC
    Reprod Biomed Online; 2009 Aug; 19(2):216-20. PubMed ID: 19712557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
    Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
    Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes.
    Gris JC; Balducchi JP; Quéré I; Hoffet M; Marès P
    Thromb Haemost; 2002 Mar; 87(3):536-7. PubMed ID: 11916088
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiphospholipid antibodies, infertility and recurrent miscarriage.
    Rai R; Regan L
    Curr Opin Obstet Gynecol; 1997 Aug; 9(4):279-82. PubMed ID: 9263721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
    Dolitzky M; Inbal A; Segal Y; Weiss A; Brenner B; Carp H
    Fertil Steril; 2006 Aug; 86(2):362-6. PubMed ID: 16769056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies.
    Lin T; Chen Y; Cheng X; Li N; Sheng X
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():53-57. PubMed ID: 30660037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Ramadan DI; Fouda IM
    J Obstet Gynaecol; 2010; 30(8):842-6. PubMed ID: 21126127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
    Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
    Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome in pregnancy.
    Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):107-20, vii. PubMed ID: 18207069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
    Kutteh WH
    Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up.
    Naru T; Khurshid M; Nazir Z
    J Pak Med Assoc; 2006 Feb; 56(2):84-6. PubMed ID: 16555643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
    Song Y; Wang HY; Qiao J; Liu P; Chi HB
    Chin Med J (Engl); 2017 Feb; 130(3):267-272. PubMed ID: 28139508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.